ResearcherHarbin Medical UniversityActive in the last 2 years

Yuting Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7404-5250; OpenAlex author ID A5035796509. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Dual blockade of PD-1 and NKG2A prevents NK cell senescence and reprograms the immunosuppressive microenvironment in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2026.117583 ↗
m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma. Last author DOI 10.1007/s00432-022-04150-7 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tao Zhang · 1 shared paper, 2023 · strength 0.31
- Paper m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma. DOI 10.1007/s00432-022-04150-7 ↗
Yu Zhang · 1 shared paper, 2026 · strength 0.21
- Paper Dual blockade of PD-1 and NKG2A prevents NK cell senescence and reprograms the immunosuppressive microenvironment in pa… DOI 10.1016/j.celrep.2026.117583 ↗
Haitao Zhang · 1 shared paper, 2026 · strength 0.21
- Paper Dual blockade of PD-1 and NKG2A prevents NK cell senescence and reprograms the immunosuppressive microenvironment in pa… DOI 10.1016/j.celrep.2026.117583 ↗
Xuelei Ma · 1 shared paper, 2026 · strength 0.21
- Paper Dual blockade of PD-1 and NKG2A prevents NK cell senescence and reprograms the immunosuppressive microenvironment in pa… DOI 10.1016/j.celrep.2026.117583 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.